Ciencias de la Salud
Área
King's College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de King's College London (22)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Brain correlates of impaired goal management in bipolar mania
Psychological Medicine, Vol. 53, Núm. 3, pp. 1021-1029
-
Do the negative symptoms of schizophrenia reflect reduced responsiveness to reward? Examination using a reward prediction error (RPE) task
Psychological Medicine, Vol. 20
-
Improved estimation of the risk of manic relapse by combining clinical and brain scan data
Revista de Psiquiatria y Salud Mental
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14
-
Who cares about migraine? Pathways and hurdles in the European region - access to care III
Journal of Headache and Pain, Vol. 24, Núm. 1
2022
-
Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Nutrients, Vol. 14, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Altered brain responses to specific negative emotions in schizophrenia
NeuroImage: Clinical, Vol. 32
-
Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
Frontiers in Psychiatry, Vol. 12
2020
2018
-
Validation of the Caregiver Skills (CASK) scale in Catalonia: Concordance between caregivers in attitudes and behaviours
European Eating Disorders Review, Vol. 26, Núm. 4, pp. 329-336
2017
-
A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs
AIDS and Behavior, Vol. 21, Núm. 7, pp. 1791-1811
-
Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use
Health and Quality of Life Outcomes, Vol. 15, Núm. 1
-
Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson’s Disease
Molecular Neurobiology, Vol. 54, Núm. 8, pp. 6287-6303
2015
-
A Multisite, Randomized Controlled Clinical Trial of Computerized Cognitive Remediation Therapy for Schizophrenia
Schizophrenia Bulletin, Vol. 41, Núm. 6, pp. 1387-1396
-
Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis
Cognitive Neuropsychiatry, Vol. 20, Núm. 2, pp. 144-156
-
Influence of the APOE ε4 allele and mild cognitive impairment diagnosis in the disruption of the MEG resting state functional connectivity in sources space
Journal of Alzheimer's Disease, Vol. 44, Núm. 2, pp. 493-505
2014
-
Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?
Schizophrenia Research, Vol. 157, Núm. 1-3, pp. 271-277
2013
-
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone
Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625